Madam Speaker, for some time now, the NDP has been calling on the government to establish a national pharmacare program that would cover everything.
However, the agreement we are currently discussing, and that the government wants to get signed quickly, includes patent extensions that would make pharmacare even harder and more expensive to implement.
Does my colleague not think that this kind of clause in the agreement with the United States and Mexico will hinder the implementation of a pharmacare program?